Botulinum toxin therapy during the Covid 19 outbreak: Experience of an Italian multidisciplinary team.

We read with great interest the letter by Leocani and coworkers "Disability through COVID-19 pandemic: neurorehabilitation cannot wait". We agree with their report of how the COVID-19 epidemic countermeasures affected Neurorehabilitation facilities in Italy (1) and we endorse the Authors' position concerning the importance of providing timely disability management even in the pandemic phase. At the same time, given the necessity to adapt protections from COVID-19 exposure for patients and staff, multidisciplinary teams have to reorganize work routine with the support of digital technology .